Canada markets open in 2 hours 38 minutes

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.61+0.01 (+0.18%)
At close: 04:00PM EDT
5.73 +0.12 (+2.14%)
After hours: 07:38PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 748.89M
Enterprise Value 591.93M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)41.02
Price/Book (mrq)11.08
Enterprise Value/Revenue 83.04
Enterprise Value/EBITDA -2.49

Trading Information

Stock Price History

Beta (5Y Monthly) 2.69
52-Week Change 3-22.94%
S&P500 52-Week Change 3-12.21%
52 Week High 39.49
52 Week Low 32.50
50-Day Moving Average 35.36
200-Day Moving Average 35.49

Share Statistics

Avg Vol (3 month) 3840.59k
Avg Vol (10 day) 31.37M
Shares Outstanding 5126.08M
Implied Shares Outstanding 6N/A
Float 894.47M
% Held by Insiders 16.59%
% Held by Institutions 184.89%
Shares Short (Feb 27, 2023) 47.82M
Short Ratio (Feb 27, 2023) 410.41
Short % of Float (Feb 27, 2023) 48.77%
Short % of Shares Outstanding (Feb 27, 2023) 46.24%
Shares Short (prior month Jan 30, 2023) 46.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-3,458.05%

Management Effectiveness

Return on Assets (ttm)-43.79%
Return on Equity (ttm)-351.62%

Income Statement

Revenue (ttm)7.13M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-86.50%
Gross Profit (ttm)-165.79M
EBITDA -239.86M
Net Income Avi to Common (ttm)-250.16M
Diluted EPS (ttm)-2.44
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)181.34M
Total Cash Per Share (mrq)1.44
Total Debt (mrq)162.59M
Total Debt/Equity (mrq)1,507.84
Current Ratio (mrq)2.28
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-228.82M
Levered Free Cash Flow (ttm)-129.43M